Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T de Witte

Showing results (121-130 of 264) with videos related to

Pageof 27
Sort By:
Blut|October 1, 1986
Ceftazidime does not enhance cyclosporin-A nephrotoxicity in febrile bone marrow transplantation patientsC Verhagen, B E de Pauw, T de Witte, et al.
The Journal of Infection|September 1, 1986
Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patientsC Verhagen, B E de Pauw, J P Donnelly, et al.
British Journal of Haematology|January 29, 2000
Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusionN Schaap, A Schattenberg, B Bär, et al.
British Journal of Haematology|June 1, 1993
Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reactionJ P Meijerink, T F Smetsers, J M Raemaekers, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1987
Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patientsC S Verhagen, B de Pauw, T de Witte, et al.
Blood|April 1, 1989
Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapseA Schattenberg, T De Witte, M Salden, et al.
Experimental Hematology|July 1, 1993
Interphase cytogenetics on agar cultures: a novel approach to determine chromosomal aberrations in hematopoietic progenitor cellsP J Poddighe, N Van der Lely, G P Vooijs, et al.
Bone Marrow Transplantation|November 1, 1994
Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remissionT De Witte, B Awwad, J Boezeman, et al.
Bone Marrow Transplantation|July 5, 2001
TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cellsH Dolstra, H Fredrix, A van der Meer, et al.
British Journal of Haematology|February 1, 1997
A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicityM Smeets, R Raymakers, G Vierwinden, et al.
Pageof 27

Showing results (121-130 of 264) with videos related to

Sort By:
Pageof 27
Blut|October 1, 1986
Ceftazidime does not enhance cyclosporin-A nephrotoxicity in febrile bone marrow transplantation patientsC Verhagen, B E de Pauw, T de Witte, et al.
The Journal of Infection|September 1, 1986
Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patientsC Verhagen, B E de Pauw, J P Donnelly, et al.
British Journal of Haematology|January 29, 2000
Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T-cell-depleted bone marrow transplantation and after donor leucocyte infusionN Schaap, A Schattenberg, B Bär, et al.
British Journal of Haematology|June 1, 1993
Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reactionJ P Meijerink, T F Smetsers, J M Raemaekers, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1987
Randomized prospective study of ceftazidime versus ceftazidime plus cephalothin in empiric treatment of febrile episodes in severely neutropenic patientsC S Verhagen, B de Pauw, T de Witte, et al.
Blood|April 1, 1989
Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapseA Schattenberg, T De Witte, M Salden, et al.
Experimental Hematology|July 1, 1993
Interphase cytogenetics on agar cultures: a novel approach to determine chromosomal aberrations in hematopoietic progenitor cellsP J Poddighe, N Van der Lely, G P Vooijs, et al.
Bone Marrow Transplantation|November 1, 1994
Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remissionT De Witte, B Awwad, J Boezeman, et al.
Bone Marrow Transplantation|July 5, 2001
TCR gamma delta cytotoxic T lymphocytes expressing the killer cell-inhibitory receptor p58.2 (CD158b) selectively lyse acute myeloid leukemia cellsH Dolstra, H Fredrix, A van der Meer, et al.
British Journal of Haematology|February 1, 1997
A low but functionally significant MDR1 expression protects primitive haemopoietic progenitor cells from anthracycline toxicityM Smeets, R Raymakers, G Vierwinden, et al.
Pageof 27